Free tool
Diagnostics stocks
We cover 55 companies grouped under the Diagnostics theme. The median market value in the group is $392.35M. Across the group, the median move over the past trading day is −0.66%. 54% of the 54 with a 200-day average trade above it. Price change over the past year runs from −47.0% to +103.0% across the middle 80 percent of the group, with a median of −8.5%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
55 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| SHL.AX | Sonic Healthcare Limited | 20.12 AUD | −11.44% | −8.60% | −11.84% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% |
| 4544.T | H.U. Group Holdings, Inc. | 3,634.00 JPY | +1.08% | +8.30% | +2.77% |
| OPK | OPKO Health, Inc. | $1.51 | −8.48% | +18.90% | +6.34% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| 4694.T | BML, Inc. | 3,625.00 JPY | −2.03% | −3.47% | +5.42% |
| IDX.AX | Integral Diagnostics Limited | 2.30 AUD | +10.05% | −7.10% | −19.60% |
| DASA3.SA | Diagnósticos da América S.A. | 2.61 BRL | −1.51% | −41.74% | +93.33% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | +0.92% | −22.59% | −8.46% |
| 137310.KS | SD Biosensor, Inc. | 6,140.00 KRW | +1.66% | −30.67% | −38.35% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,296.00 JPY | −8.71% | −3.54% | −5.16% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| VOX.WA | Voxel S.A. | 134.20 PLN | +6.85% | +10.36% | −18.11% |
| ACL.AX | Australian Clinical Labs Limited | 2.81 AUD | +15.64% | +4.75% | +5.46% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| NNNN | Anbio Biotechnology | $7.72 | −23.94% | −73.81% | −83.55% |
| 197A.T | TAUNS LABORATORIES INC. | 504.00 JPY | +4.56% | −0.59% | −11.13% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −9.00% | −21.91% | +16.89% |
| MYGN | Myriad Genetics, Inc. | $3.12 | −41.35% | −49.19% | −47.39% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| OSUR | OraSure Technologies, Inc. | $3.71 | −7.71% | +55.88% | +11.08% |
| HLS.AX | Healius Limited | 0.45 AUD | +20.00% | −50.55% | −50.55% |
| ALERS.PA | Eurobio Scientific Société anonyme | 19.80 EUR | −6.60% | −18.01% | −21.89% |
| 4595.T | Mizuho Medy Co.,Ltd. | 1,721.00 JPY | +1.59% | −0.58% | +11.63% |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% |
| LUCD | Lucid Diagnostics Inc. | $0.97 | +6.20% | −13.33% | −22.96% |
| PEB.AX | Pacific Edge Limited | 0.20 AUD | −9.09% | +25.00% | +60.00% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,892.00 JPY | +4.82% | +10.10% | +21.78% |
| S2B.WA | Syn2bio S.A. | 63.00 PLN | −9.12% | +76.47% | +76.47% |
| EKF.L | EKF Diagnostics Holdings plc | 24.70 GBP | −5.00% | −6.97% | −15.56% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.30 | −6.72% | −39.94% | +73.39% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| SCP.WA | Scope Fluidics S.A. | 140.20 PLN | +19.83% | +0.29% | −9.90% |
| S84.F | Scope Fluidics S.A. | 27.90 EUR | +19.74% | −25.50% | −10.43% |
| QUCY | Quantum Cyber N.V. | $1.38 | +26.15% | +18.53% | −15.12% |
| BNR | Burning Rock Biotech Limited | $10.44 | +13.60% | −46.95% | +22.54% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.